Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesDRD2-related TaqIA polymorphism modulates motivation to smoke
Nicotine & Tobacco Research, 10/13/09
Gilbert DG et al. – The results support the idea that dopaminergic transmission plays an important role in the neurobiological basis of reasons for smoking and that the TaqIA variant is one of the genetic factors underlying individual differences in these aspects. These findings also have implications for improving treatment strategies to help individuals quit smoking by controlling their motivation to continue cigarette consumption.
Related Articles
Smoking Prevalence among US Veterans
Journal of General Internal Medicine, 11/10/09
Relevance Score: 94%
Cluster Headache As the Result of Secondhand Cigarette Smoke Exposure During Childhood
Headache: The Journal of Head and Face Pain, 10/07/09
Relevance Score: 94%
Active smoking and second-hand smoke exposure at home among Irish children, 1995-2007
BMJ - Archives of Diseases in Childhood, 10/29/09
Relevance Score: 93%
Cigarette smoking and cognitive impairment: A 10-year cohort study in Taiwan
Archives of Gerontology and Geriatrics, 10/19/09
Relevance Score: 93%
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09
Relevance Score: 92%
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of co-occurring disorders and intimate partner violence on substance abuse treatment outcomes
Journal of Substance Abuse Treatment, 02/09/10
The Dual Diagnosis Physician-infrastructure Assessment Tool: Examining Physician Attributes and Dual Diagnosis Capacity
Psychiatric Services, 02/09/10
A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers
Drug and Alcohol Dependence, 02/09/10
Article Search
Sponsor
Sponsor